• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Atara Biotherap(ATRA.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Atara Biotherap released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 119.18 M and EPS of USD 3.37
04:00
Atara Biotherap released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 3.453 M (forecast USD 2.739 M), actual EPS USD -0.32 (forecast USD -0.692)
04:00
Nov3
Pierre Fabre Transfers T Cell Therapy Tabelecleucel's BLA from Atara Biotherapeutics
14:02
Aug12
Atara Biotherap released FY2025 Q2 earnings on August 11 (EST), actual revenue USD 17.58 M (forecast USD 5.567 M), actual EPS USD 0.19 (forecast USD -0.065)
03:00
Atara Biotherap released FY2025 Semi-Annual earnings on August 11 (EST), actual revenue USD 115.72 M, actual EPS USD 3.49
03:00
Jul14
Atara BioTherapeutics Resubmits BLA for EBVALLO
13:21

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 3.453 M, Net Income -4.303 M, EPS -0.32

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 17.58 M, Net Income 2.387 M, EPS 0.19

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 98.15 M, Net Income 38.01 M, EPS 3.5

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
11.220
+173.66%
+7.050
ANGH
3.840
+65.52%
+1.520
ESHA
22.020
+53.13%
+7.870
SIDU
4.050
+51.69%
+1.380
NCL
0.2766
+42.58%
+0.083
RDACR
0.2493
+31.21%
+0.059
ESHAR
0.2216
+30.35%
+0.052
VNDA
8.900
+26.60%
+1.870
ORIS
1.540
+26.23%
+0.320
ULY
3.483
+26.18%
+0.723
View More